Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial.

Kenichi YamaharaAkiko HamadaToshihiro SomaRika OkamotoMasaya OkadaSatoshi YoshiharaKyoko YoshiharaKazuhiro IkegameHiroya TamakiKatsuji KaidaTakayuki InoueYuko OhsugiHiroki NishikawaHiroshi HayashiYoichi M ItoHiroaki IijimaShunsuke OhnishiDaigo HashimotoToshiyuki IsoeTakanori TeshimaHiroyasu OgawaNorihiro SatoYoshihiro Fujimori

Published in: BMJ open (2019)

UMIN000029945.

Keyphrases

stem cell transplantation
high dose
liver failure
respiratory failure
study protocol
phase iii
clinical trial
phase ii
drug induced
aortic dissection
low dose
hepatitis b virus
intensive care unit
bone marrow